GAMCO Investors Files 13D/A for Gabelli Healthcare & WellnessRx Trust

TL;DR

GAMCO updated its 13D filing for Gabelli Healthcare & WellnessRx Trust. Ownership details changed.

AI Summary

GAMCO Investors, Inc. filed an amendment (Amendment No. 5) to its Schedule 13D on March 4, 2024, regarding its holdings in Gabelli Healthcare & WellnessRx Trust. The filing details changes in beneficial ownership of the preferred shares of the issuer. GAMCO Investors, Inc. is the primary filer, with David Goldman listed as a contact person.

Why It Matters

This filing indicates potential shifts in significant ownership stakes within Gabelli Healthcare & WellnessRx Trust, which could influence the company's strategic direction or market perception.

Risk Assessment

Risk Level: medium — Schedule 13D filings often signal significant changes in beneficial ownership, which can lead to increased volatility or strategic shifts for the subject company.

Key Numbers

• Amendment No. 5 — Filing Amendment Number (Indicates this is a revised filing)
• 20240304 — Filing Date (Date the amendment was filed with the SEC)

Key Players & Entities

• GAMCO Investors, Inc. (company) — Filer of the Schedule 13D/A
• Gabelli Healthcare & WellnessRx Trust (company) — Subject company
• David Goldman (person) — Contact person for GAMCO Investors, Inc.
• Preferred Shares (security) — Class of securities held

FAQ

Key Financial Figures

• $9,100,000 — sons used an aggregate of approximately $9,100,000 to purchase the Series G shares reporte
• $4,000,000 — ivate placement. GBL used approximately $4,000,000 of working capital to purchase the Seri
• $2,000,000 — s reported by it. AC used approximately $2,000,000 of its working capital to purchase the
• $3,000,000 — ed by it. Foundation used approximately $3,000,000 of its funds to purchase the Series G s
• $100,000 — by it. Mario Gabelli used approximately $100,000 of personal funds to purchase the Serie

Filing Documents

• grxpref_05.htm (SC 13D/A) — 140KB
• 0000807249-24-000028.txt ( ) — 142KB

Security and Issuer

Item 1. Security and Issuer This Amendment No. 5 to Schedule 13D on the Preferred Shares of The Gabelli Healthcare & Wellness Rx Trust (4.00% Series E Cumulative Preferred Shares and 5.20% Series G Cumulative Preferred Shares) (the "Issuer") and is being filed on behalf of the undersigned to amend the Schedule 13D, as amended (the "Schedule 13D") which was originally filed on December 22, 2020. Unless otherwise indicated, all capitalized terms used herein but not defined shall have the same meanings as set forth in Schedule 13D.

Identity and Background

Item 2. Identity and Background

to Schedule 13D is amended, in pertinent part, as follows

Item 2 to Schedule 13D is amended, in pertinent part, as follows: This statement is being filed by various entities which except for LICT Corporation ("LICT) and CIBL, Inc. ("CIBL"), engage in various aspects of the securities business, primarily as investment adviser to various institutional and individual clients, including registered investment companies and pension plans, and as general partner or the equivalent of various private investment partnerships or private funds and as a registered broker-dealer. Certain of these entities may also make investments for their own accounts. Mario J. Gabelli ("Mario Gabelli") is deemed to directly or indirectly control these entities through his ownership interest. The foregoing persons in the aggregate often own beneficially more than 5% of a class of equity securities of a particular issuer. Although several of the foregoing persons are treated as institutional investors for purposes of reporting their beneficial ownership on the short-form Schedule 13G, the holdings of those who do not qualify as institutional investors may exceed the 1% threshold presented for filing on Schedule 13G or implementation of their investment philosophy may from time to time require action which could be viewed as not completely passive. In order to avoid any question as to whether their beneficial than on the short-form Schedule 13G and thereby to provide more expansive disclosure than may be necessary. (a), (b) and (c) - This statement is being filed by one or more of the following persons: GGCP, Inc. ("GGCP"), GGCP Holdings LLC ("GGCP Holdings"), GAMCO Investors, Inc. ("GBL"), Associated Capital Group, Inc. ("AC"), Gabelli Funds, LLC ("Gabelli Funds"), GAMCO Asset Management Inc. ("GAMCO"),

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration

to Schedule 13D is amended, in pertinent part, as follows

Item 3 to Schedule 13D is amended, in pertinent part, as follows: The Reporting Persons used an aggregate of approximately $9,100,000 to purchase the Series G shares reported as beneficially owned in Item 5 in a private placement. GBL used approximately $4,000,000 of working capital to purchase the Series G shares reported by it. AC used approximately $2,000,000 of its working capital to purchase the Series G shares reported by it. Foundation used approximately $3,000,000 of its funds to purchase the Series G shares reported by it. Mario Gabelli used approximately $100,000 of personal funds to purchase the Series G shares reported by him.

Interest In Securities Of The Issuer

Item 5. Interest In Securities Of The Issuer

to

Item 5 to Schedule 13D is amended, in pertinent part, as follows: (a) The aggregate number of Securities to which this Schedule 13D relates is 3,324,000 Preferred Shares representing 53.25% of the 6,242,000 Preferred Shares outstanding as reported by the Issuer. The Reporting Persons beneficially own those Securities as follows: Name Preferred shares % Mario Gabelli GAMCO Foundation AC GBL 1,610,000 300,000 614,000 400,000 400,000 25.79% 4.81% 9.84% 6.41% 6.41% Mario Gabelli is deemed to have beneficial ownership of the Securities owned beneficially by each of the foregoing persons. AC, GBL and GGCP are deemed to have beneficial ownership of the Securities owned beneficially by each of the foregoing persons other than Mario Gabelli and the Foundation. (b) Each of the Reporting Persons and Covered Persons has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition of the Securities reported for it, either for its own benefit or for the benefit of its investment clients or its partners, as the case may be. (c) Information with respect to all transactions in the Securities which were effected during the past sixty days or since the most recent filing on Schedule 13D, whichever is less, by each of the Reporting Persons and Covered Persons is set forth on Schedule II annexed hereto and incorporated herein by reference. (e) Not applicable. 8 Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 4, 2024 GGCP, INC. GABELLI FOUNDATION, INC. MARIO J. GABELLI By: /s/ David Goldman David Goldman Attorney-in-Fact GAMCO INVESTORS, INC. By: /s/ Peter D. Goldstein Peter D. Goldstein General Counsel – GAMCO Investors, Inc. ASSOCIATED CAPITAL GROUP, INC. GAMCO ASSET MANAGEMENT INC. By: /s/ Douglas R. Jamieson Douglas R. Jamieson President & Chief Executive Officer – Assoc

View Full Filing

View this SC 13D/A filing on SEC EDGAR